Citius Pharmaceuticals to Host Investor Call to Discuss Recent and Upcoming Developments
Citius Pharmaceuticals (Nasdaq: CTXR) has announced an investor call scheduled for Tuesday, August 13, 2024, at 8:30 AM ET. The call aims to discuss recent and upcoming developments within the company. Chairman and CEO Leonard Mazur will lead the discussion, joined by other members of the management team.
Investors can participate in the call via phone or webcast. The U.S. toll-free number is 1-888-243-4451, while the international number is 1-412-542-4135. A webcast option is also available, with registration required. A replay of the call will be accessible on the Citius website for 90 days following the event, providing an opportunity for those unable to attend live to catch up on the discussed developments.
Citius Pharmaceuticals (Nasdaq: CTXR) ha annunciato una chiamata per gli investitori programmata per martedì 13 agosto 2024, alle 8:30 AM ET. La chiamata ha l'obiettivo di discutere sviluppi recenti e futuri all'interno dell'azienda. Leonard Mazur, Presidente e CEO, guiderà la discussione, affiancato da altri membri del team di gestione.
Gli investitori possono partecipare alla chiamata tramite telefono o webcast. Il numero verde per gli Stati Uniti è 1-888-243-4451, mentre il numero internazionale è 1-412-542-4135. È disponibile anche un'opzione di webcast, con registrazione richiesta. Una registrazione della chiamata sarà accessibile sul sito web di Citius per 90 giorni dopo l'evento, offrendo un'opportunità a coloro che non possono partecipare dal vivo di recuperare gli sviluppi discussi.
Citius Pharmaceuticals (Nasdaq: CTXR) ha anunciado una llamada para los inversionistas programada para el martes 13 de agosto de 2024, a las 8:30 AM ET. La llamada tiene como objetivo discutir desarrollos recientes y próximos dentro de la empresa. Leonard Mazur, Presidente y CEO, liderará la discusión, acompañado por otros miembros del equipo de gestión.
Los inversionistas pueden participar en la llamada a través del teléfono o un webcast. El número gratuito de EE. UU. es 1-888-243-4451, mientras que el número internacional es 1-412-542-4135. También hay disponible una opción de webcast, que requiere registro. Una repetición de la llamada estará accesible en el sitio web de Citius durante 90 días después del evento, proporcionando una oportunidad para quienes no puedan asistir en vivo para ponerse al día con los desarrollos discutidos.
Citius Pharmaceuticals (Nasdaq: CTXR)가 2024년 8월 13일 화요일 오전 8시 30분 ET로 예정된 투자자 전화 회의를 발표했습니다. 이번 회의는 회사 내의 최근 및 향후 발전 사항을 논의하는 것을 목표로 하고 있습니다. 회장 겸 CEO인 레너드 마줄이 논의를 이끌며, 관리팀의 다른 멤버들도 함께 할 예정입니다.
투자자들은 전화 또는 웹캐스트를 통해 회의에 참여할 수 있습니다. 미국의 무료 전화번호는 1-888-243-4451이며, 국제 전화번호는 1-412-542-4135입니다. 웹캐스트 옵션도 제공되며, 등록이 필요합니다. 회의의 재생은 이벤트 후 90일 동안 Citius 웹사이트에서 접근할 수 있습니다, 이로 인해 실시간 참석이 불가능했던 분들이 논의된 사항을 확인할 수 있는 기회를 제공합니다.
Citius Pharmaceuticals (Nasdaq: CTXR) a annoncé une conférence téléphonique pour les investisseurs prévue pour mardi 13 août 2024 à 8h30 ET. L'appel vise à discuter des développements récents et à venir au sein de l'entreprise. Leonard Mazur, Président et PDG, animera la discussion, accompagné d'autres membres de l'équipe de direction.
Les investisseurs peuvent participer à l'appel par téléphone ou par webcast. Le numéro vert américain est le 1-888-243-4451, tandis que le numéro international est le 1-412-542-4135. Une option de webcast est également disponible, nécessitant une inscription. Une retransmission de l'appel sera accessible sur le site Web de Citius pendant 90 jours après l'événement, offrant ainsi aux personnes ne pouvant pas assister en direct la possibilité de se mettre à jour sur les développements discutés.
Citius Pharmaceuticals (Nasdaq: CTXR) hat eine Investor Call angekündigt, die für Dienstag, den 13. August 2024, um 8:30 Uhr ET geplant ist. Ziel des Anrufs ist es, aktuelle und zukünftige Entwicklungen im Unternehmen zu besprechen. Leonard Mazur, Chairman und CEO, wird die Diskussion leiten, unterstützt von weiteren Mitgliedern des Management-Teams.
Investoren können telefonisch oder über einen Webcast an dem Anruf teilnehmen. Die kostenlose Nummer in den USA lautet 1-888-243-4451, während die internationale Nummer 1-412-542-4135 ist. Eine Webcast-Option ist ebenfalls verfügbar, wobei eine Registrierung erforderlich ist. Eine Wiederholung des Anrufs wird auf der Citius-Website 90 Tage nach der Veranstaltung zugänglich sein, sodass diejenigen, die nicht live teilnehmen konnten, die besprochenen Entwicklungen nachholen können.
- None.
- None.
Management call scheduled for Tuesday, August 13, 2024, at 8:30 AM ET
Citius Chairman and CEO, Leonard Mazur, will be joined by members of the management team. A question and answer period will follow management's discussion.
Conference Call Details:
Date: | Tuesday, August 13, 2024 |
Time: | 8:30 a.m. Eastern Time |
Dial In: | 1-888-243-4451 ( 1-412-542-4135 (international) |
Webcast: | Register for the webcast here. A replay will be available on the Citius website (www.citiuspharma.com) for 90 days following the event. |
About Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products. In August 2024, the FDA approved LYMPHIR, a targeted immunotherapy for an initial indication in the treatment of cutaneous T-cell lymphoma. Citius Pharma's late-stage pipeline also includes Mino-Lok®, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections, and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. A Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido were completed in 2023. Mino-Lok met primary and secondary endpoints of its Phase 3 Trial. Citius is actively engaged with the FDA to outline next steps for both programs. For more information, please visit www.citiuspharma.com.
Investor Contact:
Ilanit Allen
ir@citiuspharma.com
908-967-6677 x113
Media Contact:
STiR-communications
Greg Salsburg
Greg@STiR-communications.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/citius-pharmaceuticals-to-host-investor-call-to-discuss-recent-and-upcoming-developments-302219218.html
SOURCE Citius Pharmaceuticals, Inc.
FAQ
When is Citius Pharmaceuticals (CTXR) hosting its investor call?
What will be discussed during the Citius Pharmaceuticals (CTXR) investor call?
How can investors participate in the Citius Pharmaceuticals (CTXR) call on August 13, 2024?
Will there be a replay available for the Citius Pharmaceuticals (CTXR) investor call?
